340 related articles for article (PubMed ID: 10555890)
1. Associates of health status in patients with systemic lupus erythematosus.
Sutcliffe N; Clarke AE; Levinton C; Frost C; Gordon C; Isenberg DA
J Rheumatol; 1999 Nov; 26(11):2352-6. PubMed ID: 10555890
[TBL] [Abstract][Full Text] [Related]
2. Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.
Da Costa D; Dobkin PL; Fitzcharles MA; Fortin PR; Beaulieu A; Zummer M; Senécal JL; Goulet JR; Rich E; Choquette D; Clarke AE
J Rheumatol; 2000 Feb; 27(2):365-72. PubMed ID: 10685798
[TBL] [Abstract][Full Text] [Related]
3. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic status and health in women with systemic lupus erythematosus.
Lotstein DS; Ward MM; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM
J Rheumatol; 1998 Sep; 25(9):1720-9. PubMed ID: 9733452
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus.
Karlson EW; Liang MH; Eaton H; Huang J; Fitzgerald L; Rogers MP; Daltroy LH
Arthritis Rheum; 2004 Jun; 50(6):1832-41. PubMed ID: 15188360
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
Vu TV; Escalante A
J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
[TBL] [Abstract][Full Text] [Related]
7. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls.
Gilboe IM; Kvien TK; Husby G
J Rheumatol; 1999 Aug; 26(8):1694-700. PubMed ID: 10451064
[TBL] [Abstract][Full Text] [Related]
8. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?
Jolly M
J Rheumatol; 2005 Sep; 32(9):1706-8. PubMed ID: 16142864
[TBL] [Abstract][Full Text] [Related]
9. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
[TBL] [Abstract][Full Text] [Related]
10. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.
Clarke AE; Petri MA; Manzi S; Isenberg DA; Gordon C; Senecal JL; St Pierre Y; Joseph L; Penrod J; Fortin PR; Sutcliffe N; Goulet JR; Choquette D; Grodzicky T; Danoff DS; Ho V; Esdaile JM
J Rheumatol; 1999 Jul; 26(7):1500-11. PubMed ID: 10405937
[TBL] [Abstract][Full Text] [Related]
11. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
Gilboe IM; Kvien TK; Husby G
J Rheumatol; 2001 Feb; 28(2):266-74. PubMed ID: 11246660
[TBL] [Abstract][Full Text] [Related]
12. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
[TBL] [Abstract][Full Text] [Related]
13. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
Wolfe F; Michaud K; Li T; Katz RS
J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
[TBL] [Abstract][Full Text] [Related]
14. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
Colangelo KJ; Pope JE; Peschken C
J Rheumatol; 2009 Oct; 36(10):2231-7. PubMed ID: 19723907
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial correlates of morbidity in women with systemic lupus erythematosus.
Ward MM; Lotstein DS; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM
J Rheumatol; 1999 Oct; 26(10):2153-8. PubMed ID: 10529132
[TBL] [Abstract][Full Text] [Related]
16. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
[TBL] [Abstract][Full Text] [Related]
17. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
19. Relationship between flare and health-related quality of life in patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
J Rheumatol; 2010 Mar; 37(3):568-73. PubMed ID: 20110519
[TBL] [Abstract][Full Text] [Related]
20. Fibromyalgia is a major contributor to quality of life in lupus.
Gladman DD; Urowitz MB; Gough J; MacKinnon A
J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
